The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...
Generics Awareness Month took center stage at the Mercury Drug Q-Plaza Branch in Cainta recently, where RHEA Generics, in support of the Department of Health (DOH) and in partnership with Mercury Drug ...
Earlier this year, Canada became the first major market in the world where generic forms of semaglutide became legal. The competition was on: Manufacturers raced to secure Health Canada approval so ...
Amarin Pharma has not done enough to definitively show that its generic competitor, Hikma Pharmaceuticals, is infringing on Amarin's patents for its anti-hypertriglyceridemia drug icosapent ethyl ...
WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's (HIK.L), opens new tab generic version of Amarin Pharma's (AMRN.O), opens new tab cardiovascular medication Vascepa did not infringe Amarin's patents, ...
Each day, millions of people pick up a prescription drug from their local pharmacy or mailbox. Most are affordable, with co-pays on average less than $7 for 90% of drugs. But for a growing number of ...
In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...
Actress and hands-on mom Judy Ann Santos, together with her mother, Mommy Carol, headlines the campaign—underscoring the multi-generational trust in TGP Generics. TGP reminds Filipinos why it remains ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
The controversial topic of authorized generics has been in the news again recently following a case in which Mylan Pharmaceuticals tried to sue the FDA for approving an authorized generic version of ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results